Abstract
This brief review highlights new ideas about the role of the sympathetic nervous system in human blood pressure regulation. We emphasize how this role varies with age and sex and use our findings to raise questions about the sympathetic nervous system and hypertension in humans. We also focus on three additional areas, including (1) novel ideas about the carotid body and sympathoexcitation as it relates to hypertension, (2) clinical trials of renal denervation that attempted to treat hypertension by reducing ongoing sympathoexcitation, and (3) new ideas about resistant hypertension and cerebral blood flow. We further highlight that success of device-based therapy to modulate the sympathetic nervous system relies heavily on patient selection. Furthermore, data suggest that the majority of patients respond to anti-hypertensive therapy and the major cause of “resistant” hypertension is poor patient adherence. While the enthusiasm for device therapy or perhaps even “precision medicine” is high, it is likely that by far the most benefit to the most patients will occur via better screening, more aggressive therapy, and the development of strategies that improve patient adherence to medication regimens and lifestyle changes.
Original language | English (US) |
---|---|
Article number | 7 |
Pages (from-to) | 1-6 |
Number of pages | 6 |
Journal | Current Hypertension Reports |
Volume | 18 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2016 |
Keywords
- Aging
- Cerebral blood flow
- Chemoreceptors
- Hypertension
- Renal denervation
- Sex
- Sympathetic nervous system
ASJC Scopus subject areas
- Internal Medicine